Peritoneal mesothelioma patients have a few different treatment options available. This session discusses two options: surgery as well as hyperthermic intraperitoneal chemotherapy (HIPEC).
This session is presented by:
Jason Foster, MD, University of Nebraska
Travis Grotz, MD, Mayo Clinic
This is a recording of a session at the 2024 International Symposium on Malignant Mesothelioma. This symposium is made possible by our generous sponsors: Belluck and Fox, LLP; Dean Omar Branham Shirley, LLP; Maune Raichle Hartley French & Mudd, LLC (MRHFM); Merck; The Gori Law Firm; Bristol Myers Squibb; Early Lucarelli Sweeney & Meisenkothen
Find other recorded sessions and more information at www.curemeso.org/symposium
